Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00871754 · ClinicalTrials.gov registry record
Molecular Analysis Of Bladder Cancer
A clinical trial of Bladder Cancer and Bladder Neoplasms, sponsored by Lahey Clinic.
- Active
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT00871754 is a study of Bladder Cancer and Bladder Neoplasms that is active but no longer recruiting, run by Lahey Clinic. The registered enrollment target is 5,000 participants, below the 12,725-participant average among 175 other Bladder Cancer trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00871754, a study of Bladder Cancer and Bladder Neoplasms, is active but no longer recruiting, sponsored by Lahey Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.
Conditions Studied
Study Locations (1)
Massachusetts
- Lahey Clinic - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 1988-04 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00871754
The ClinicalTrials.gov registry entry for NCT00871754 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,725-participant average among 175 other Bladder Cancer trials with a reported enrollment target (61% lower). The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bladder Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00871754 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00871754 about?
NCT00871754 is a clinical study titled "Molecular Analysis Of Bladder Cancer". This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.
What is the current status of trial NCT00871754?
This trial is currently active not recruiting. The enrollment target is 5,000 participants. The study started on 1988-04. Estimated completion is 2028-12.
What conditions does trial NCT00871754 study?
This clinical trial studies the following conditions: Bladder Cancer, Bladder Neoplasms.
Who is sponsoring clinical trial NCT00871754?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00871754 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
RECRUITING · Phase 1
-
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
RECRUITING · NA
-
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
RECRUITING · Phase 1
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.